Distinct Airway Involvement in Subtypes of End-Stage Fibrotic Pulmonary Sarcoidosis.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
08 2021
Historique:
received: 18 08 2020
revised: 17 11 2020
accepted: 04 01 2021
pubmed: 14 1 2021
medline: 4 1 2022
entrez: 13 1 2021
Statut: ppublish

Résumé

Sarcoidosis is a systemic granulomatous disease that in most patients affects the lung. Pulmonary fibrotic sarcoidosis is clinically, radiologically, and pathologically a heterogeneous condition. Although substantial indirect evidence suggests small airways involvement, direct evidence currently is lacking. What is the role of the (small) airways in fibrotic sarcoidosis? Airway morphologic features were investigated in seven explant lungs with end-stage fibrotic sarcoidosis using a combination of CT scanning (large airways), micro-CT scanning (small airways), and histologic examination and compared with seven unused donor lungs as controls with specific attention focused on different radiologically defined sarcoidosis subtypes. Patients with central bronchial distortion (n = 3), diffuse bronchiectasis (n = 3), and usual interstitial pneumonia pattern (n = 1) were identified based on CT scan, showing a decrease and narrowing of large airways, a similar airway number and increased airway diameter of more distal airways, or an increase in airway number and airway diameter, respectively, compared with control participants. The number of terminal bronchioles per milliliter and the total number of terminal bronchioles were decreased in all forms of fibrotic sarcoidosis. Interestingly, the number of terminal bronchioles was inversely correlated with the degree of fibrosis. Furthermore, we identified granulomatous remodeling as a cause of small airways loss using serial micro-CT scanning and histologic examination. The large airways are involved differentially in subtypes of sarcoidosis, but the terminal bronchioles universally are lost. This suggests that small airways loss forms an important aspect in the pathophysiologic features of fibrotic pulmonary sarcoidosis.

Sections du résumé

BACKGROUND
Sarcoidosis is a systemic granulomatous disease that in most patients affects the lung. Pulmonary fibrotic sarcoidosis is clinically, radiologically, and pathologically a heterogeneous condition. Although substantial indirect evidence suggests small airways involvement, direct evidence currently is lacking.
RESEARCH QUESTION
What is the role of the (small) airways in fibrotic sarcoidosis?
STUDY DESIGN AND METHODS
Airway morphologic features were investigated in seven explant lungs with end-stage fibrotic sarcoidosis using a combination of CT scanning (large airways), micro-CT scanning (small airways), and histologic examination and compared with seven unused donor lungs as controls with specific attention focused on different radiologically defined sarcoidosis subtypes.
RESULTS
Patients with central bronchial distortion (n = 3), diffuse bronchiectasis (n = 3), and usual interstitial pneumonia pattern (n = 1) were identified based on CT scan, showing a decrease and narrowing of large airways, a similar airway number and increased airway diameter of more distal airways, or an increase in airway number and airway diameter, respectively, compared with control participants. The number of terminal bronchioles per milliliter and the total number of terminal bronchioles were decreased in all forms of fibrotic sarcoidosis. Interestingly, the number of terminal bronchioles was inversely correlated with the degree of fibrosis. Furthermore, we identified granulomatous remodeling as a cause of small airways loss using serial micro-CT scanning and histologic examination.
INTERPRETATION
The large airways are involved differentially in subtypes of sarcoidosis, but the terminal bronchioles universally are lost. This suggests that small airways loss forms an important aspect in the pathophysiologic features of fibrotic pulmonary sarcoidosis.

Identifiants

pubmed: 33440183
pii: S0012-3692(21)00025-8
doi: 10.1016/j.chest.2021.01.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

562-571

Informations de copyright

Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Stijn E Verleden (SE)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium. Electronic address: stijn.verleden@kuleuven.be.

Arno Vanstapel (A)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Laurens De Sadeleer (L)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Adriana Dubbeldam (A)

Department of Radiology, UH Leuven, Leuven, Belgium.

Tinne Goos (T)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Iwein Gyselinck (I)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Vincent Geudens (V)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Janne Kaes (J)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Dirk E Van Raemdonck (DE)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium; Department of Thoracic Surgery, UH Leuven, Leuven, Belgium.

Laurens J Ceulemans (LJ)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium; Department of Thoracic Surgery, UH Leuven, Leuven, Belgium.

Jonas Yserbyt (J)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Robin Vos (R)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Bart Vanaudenaerde (B)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Birgit Weynand (B)

Department of Pathology, UH Leuven, Leuven, Belgium.

Johny Verschakelen (J)

Department of Radiology, UH Leuven, Leuven, Belgium.

Wim A Wuyts (WA)

BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH